Home > > Global Inhaled Nitric Oxide Delivery Systems Market Report
The Inhaled Nitric Oxide Delivery Systems market was valued at $268.6 Million in 2022, and is projected to reach $514.6 Million by 2032 growing at a CAGR of 6.77% from 2023 to 2032.Inhaled nitric oxide (INO) delivery systems are used to deliver nitric oxide gas to the respiratory system of patients with acute respiratory distress syndrome (ARDS) and other conditions. The INO delivery systems market is driven by factors such as the increasing incidence of ARDS and other respiratory conditions, the growing demand for non-invasive respiratory support, and the availability of technologically advanced INO delivery systems. Opportunities in the market include the development of portable INO delivery systems for use in ambulatory settings and home care, and the expansion of the market into emerging economies. One trend in the INO delivery systems market is the increasing adoption of continuous INO delivery systems, which offer a more precise and consistent delivery of nitric oxide compared to traditional bolus delivery systems. Top companies in the INO delivery systems market include Inogen, INO Therapeutics, and Nox Medical. These companies have developed a range of INO delivery systems, including portable devices for ambulatory use and continuous flow systems for use in hospitals and other care settings. In recent years, these companies have also focused on expanding their product portfolios and distribution networks to reach a wider customer base.